CATCo Regulatory News (CAT)

3 Jan 2006 07:00

Cambridge Antibody Tech Group PLC30 December 2005 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer Cambridge Antibody Technology Group plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director John Aston 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person As in 3. above 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest As in 3. above 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary 10 Pence Shares 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Greenwood Nominees Limited 8 State the nature of the transaction Allotment and issue of new shares in the Company issued at the average midmarket quotation as derived from the Daily Official List for the three businessdays preceding 30 December 2005 such shares having been acquired for the purposeof the Matching Share element of the Executive Incentive Plan. 9. Number of shares, debentures or financial instruments relating to sharesacquired 3,816 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.007% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction £6.976 14. Date and place of transaction 30 December 2005 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 76,556 16. Date issuer informed of transaction 30 December 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 30 December 2005 18. Period during which or date on which it can be exercised 30 December 2008 to 29 December 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 11,448 Ordinary 10 Pence Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 pence per share under option 22. Total number of shares or debentures over which options held followingnotification 124,988 of which: 14,161 are options under the Company Share Option Plan 82,507are Restricted Shares under the Executive Incentive Plan 28,329 are Matching Shares under the Executive Incentive Plan 23. Any additional information Generally speaking all shares under option are subject to performanceconditions, details of which can be obtained from the office of the CompanySecretary 24. Name of contact and telephone number for queries Justin Hoskins 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification Justin Hoskins, Company Secretary Date of notification 30 December 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer Cambridge Antibody Technology Group plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director Peter Chambre 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person As in 3. above 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest As in 3. above 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary 10 Pence Shares 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Greenwood Nominees Limited 8 State the nature of the transaction Allotment and issue of new shares in the Company issued at the average midmarket quotation as derived from the Daily Official List for the three businessdays preceding 30 December 2005 such shares having been acquired for the purposeof the Matching Share element of the Executive Incentive Plan. 9. Number of shares, debentures or financial instruments relating to sharesacquired 2,150 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.004% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction £6.976 14. Date and place of transaction 30 December 2005 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 28,592 16. Date issuer informed of transaction 30 December 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 30 December 2005 18. Period during which or date on which it can be exercised 30 December 2008 to 29 December 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 6,450 Ordinary 10 Pence Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 pence per share under option 22. Total number of shares or debentures over which options held followingnotification 387,522 of which: 191,969 are options under the Company Share Option Plan 145,021 are Restricted Shares under the Executive Incentive Plan 50,532 are Matching Shares under the Executive Incentive Plan 23. Any additional information Generally speaking all shares under option are subject to performanceconditions, details of which can be obtained from the office of the CompanySecretary 24. Name of contact and telephone number for queries Justin Hoskins 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification Justin Hoskins, Company Secretary Date of notification 30 December 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer Cambridge Antibody Technology Group plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director Alexander Duncan 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person As in 3. above 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest As in 3. above 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary 10 Pence Shares 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Greenwood Nominees Limited 8 State the nature of the transaction Allotment and issue of new shares in the Company issued at the average midmarket quotation as derived from the Daily Official List for the three businessdays preceding 30 December 2005 such shares having been acquired for the purposeof the Matching Share element of the Executive Incentive Plan. 9. Number of shares, debentures or financial instruments relating to sharesacquired 716 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.001% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction £6.976 14. Date and place of transaction 30 December 2005 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 15,155 16. Date issuer informed of transaction 30 December 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 30 December 2005 18. Period during which or date on which it can be exercised 30 December 2008 to 29 December 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 2,148 Ordinary 10 Pence Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 pence per share under option 22. Total number of shares or debentures over which options held followingnotification 66,951 of which: 31,776 are options under the Company Share Option Plan 29,640 are Restricted Shares under the Executive Incentive Plan 5,535 are Matching Shares under the Executive Incentive Plan 23. Any additional information Generally speaking all shares under option are subject to performanceconditions, details of which can be obtained from the office of the CompanySecretary 24. Name of contact and telephone number for queries Justin Hoskins 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification Justin Hoskins, Company Secretary Date of notification 30 December 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer Cambridge Antibody Technology Group plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director Lynn Lester 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person As in 3. above 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest As in 3. above 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary 10 Pence Shares 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Greenwood Nominees Limited 8 State the nature of the transaction Allotment and issue of new shares in the Company issued at the average midmarket quotation as derived from the Daily Official List for the three businessdays preceding 30 December 2005 such shares having been acquired for the purposeof the Matching Share element of the Executive Incentive Plan. 9. Number of shares, debentures or financial instruments relating to sharesacquired 286 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0005% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction £6.976 14. Date and place of transaction 30 December 2005 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 2,710 16. Date issuer informed of transaction 30 December 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 30 December 2005 18. Period during which or date on which it can be exercised 30 December 2008 to 29 December 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) Ordinary 10 Pence Shares 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 pence per share under option 22. Total number of shares or debentures over which options held followingnotification 25,764 of which: 12,361 are options under the Company Share Option Plan 10,421 are Restricted Shares under the Executive Incentive Plan 2,982 are Matching Shares under the Executive Incentive Plan 23. Any additional information Generally speaking all shares under option are subject to performanceconditions, details of which can be obtained from the office of the CompanySecretary 24. Name of contact and telephone number for queries Justin Hoskins 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification Justin Hoskins, Company Secretary Date of notification 30 December 2005 END This information is provided by RNS The company news service from the London Stock Exchange